HAE

120.2230.12%
CA

Christopher A. Simon

CEO, President & Director

Mr. Christopher A. Simon, also known as Chris, has been the Chief Executive Officer and President of Haemonetics Corporation since May 16, 2016 and has been its Director since May 2016. He joined Haemonetics Corporation in May 2016. He is Independent Director of Sotera Health Company from August 1, 2024. Mr. Simon served as a Senior Partner and Leader at McKinsey & Company's Pharmaceutical and Medical Products Practice in North America and led its work on medical products globally. He has served as Regional Operations Manager at Baxter Healthcare. Mr. Simon was a consultant with McKinsey & Company began in 1993 and was the Lead Partner for McKinsey & Company’s strategy review with Haemonetics that launched in October 2015, he has led various domestic and global engagements for a leading pharmaceutical manufacturer that included the development of growth and capabilities strategy for launching multiple products, licensing and acquisition strategy, marketing strategy for global product lifecycle management and redesign of development capabilities for a diversified med tech manufacturer with the aim of reducing time to market, improving regulatory affairs and accelerating product launch. He served as an Infantry Officer with the United States Army’s 1st Ranger Battalion. He has considerable experience in addressing strategic and operational issues in pharmaceuticals, biotechnology, diversified health care services companies and medical device manufacturers. Together with management and the Board, he was the co-architect of the strategic plan that Haemonetics Corp. For many years, he has worked with clients in healthcare and consumer goods. Mr. Simon served in commercial roles with Baxter Healthcare Corporation. He serves on the Board of Directors of AdvaMed. He serves as a Director of McKinsey & Company. Mr. Simon served as a Member of Advisory Board at Safeguard Scientifics, Inc. since April 2006 and served as its Member of Life Sciences Advisory Board. Mr. Simon earned an M.B.A. degree with distinction from Harvard Business School and B.S. in Economics magna cum laude from the Wharton School at the University of Pennsylvania, where he majored in Finance and Decision Sciences.

Positions